PT703779E - TABLETS CONTAINING ENZYMES AND PROCESSES FOR THEIR PREPARATION - Google Patents

TABLETS CONTAINING ENZYMES AND PROCESSES FOR THEIR PREPARATION

Info

Publication number
PT703779E
PT703779E PT94918764T PT94918764T PT703779E PT 703779 E PT703779 E PT 703779E PT 94918764 T PT94918764 T PT 94918764T PT 94918764 T PT94918764 T PT 94918764T PT 703779 E PT703779 E PT 703779E
Authority
PT
Portugal
Prior art keywords
pct
preparation
processes
sec
tablets containing
Prior art date
Application number
PT94918764T
Other languages
Portuguese (pt)
Inventor
Inge Helmer Knap
Breian Knudsen
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Publication of PT703779E publication Critical patent/PT703779E/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0047—Detergents in the form of bars or tablets
    • C11D17/0065—Solid detergents containing builders
    • C11D17/0073—Tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/189—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38672—Granulated or coated enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PCT No. PCT/DK94/00237 Sec. 371 Date Nov. 28, 1995 Sec. 102(e) Date Nov. 28, 1995 PCT Filed Jun. 16, 1994 PCT Pub. No. WO95/00121 PCT Pub. Date Jan. 5, 1995This invention relates to a directly compressible enzyme powder produced by mixing a liquid enzyme preparation with a suitable carrier, using the principle of wet granulation, whereby the step of freeze drying and spray-drying is avoided. The resulting enzyme powder has extraordinary good compression qualities and may directly be tabletted.
PT94918764T 1993-06-18 1994-06-16 TABLETS CONTAINING ENZYMES AND PROCESSES FOR THEIR PREPARATION PT703779E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93719A DK71993D0 (en) 1993-06-18 1993-06-18 ENZYME

Publications (1)

Publication Number Publication Date
PT703779E true PT703779E (en) 2002-04-29

Family

ID=8096755

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94918764T PT703779E (en) 1993-06-18 1994-06-16 TABLETS CONTAINING ENZYMES AND PROCESSES FOR THEIR PREPARATION

Country Status (15)

Country Link
US (1) US5885618A (en)
EP (1) EP0703779B1 (en)
JP (1) JP3559042B2 (en)
KR (1) KR100370257B1 (en)
CN (1) CN1103587C (en)
AT (1) ATE207739T1 (en)
AU (1) AU681159B2 (en)
BR (1) BR9406845A (en)
CA (1) CA2165284A1 (en)
DE (1) DE69428897T2 (en)
DK (2) DK71993D0 (en)
ES (1) ES2167368T3 (en)
NZ (1) NZ267601A (en)
PT (1) PT703779E (en)
WO (1) WO1995000121A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1135265C (en) * 1996-04-12 2004-01-21 诺沃奇梅兹有限公司 Enzyme-containing granules and process for production thereof
PL191399B1 (en) 1996-10-28 2006-05-31 Gen Mills Inc Method of obtaining distinct particles of controllable release by embedding in a base and encapsulating sensitive components
US6100080A (en) * 1996-12-18 2000-08-08 Novo Nordisk A/S Method for enzymatic treatment of biofilm
US6136578A (en) * 1997-03-12 2000-10-24 Novo Nordisk A/S Storage-stable liquid formulation comprising a laccase
TW409035B (en) 1997-06-04 2000-10-21 Gist Brocades Bv Starch-based enzyme granulates
AU747549B2 (en) 1998-03-23 2002-05-16 General Mills Inc. Encapsulation of components into edible products
US6656922B2 (en) * 1998-05-28 2003-12-02 Mediplex Corporation, Korea Oral delivery of macromolecules
US6270790B1 (en) 1998-08-18 2001-08-07 Mxneil-Ppc, Inc. Soft, convex shaped chewable tablets having reduced friability
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
US6783757B2 (en) * 2000-06-01 2004-08-31 Kirkman Group, Inc. Composition and method for increasing exorphin catabolism to treat autism
US6468568B1 (en) 2000-06-16 2002-10-22 General Mills, Inc. Oligosaccharide encapsulated mineral and vitamin ingredients
US6436453B1 (en) 2000-06-16 2002-08-20 General Mills, Inc. Production of oil encapsulated minerals and vitamins in a glassy matrix
US6558718B1 (en) 2000-06-19 2003-05-06 General Mills, Inc. Nutrient clusters for food products and methods of preparation
GB0020379D0 (en) * 2000-08-21 2000-10-04 Clariant Int Ltd Enzyme composition in tablet form
US20040071685A1 (en) * 2002-10-09 2004-04-15 Devin Houston Compositions and methods for increasing the bioavailability of plant polyphenols
WO2007008776A1 (en) * 2005-07-11 2007-01-18 Genencor International, Inc. Enzyme fabric care tablets for consumers and methods
US7803413B2 (en) 2005-10-31 2010-09-28 General Mills Ip Holdings Ii, Llc. Encapsulation of readily oxidizable components
WO2008127777A1 (en) * 2007-02-14 2008-10-23 Solomon Neil A A lactase formulation
AU2009214868A1 (en) 2008-02-14 2009-08-20 Danisco Us Inc. Small enzyme-containing granules
US20160081356A1 (en) * 2013-04-30 2016-03-24 Dupont Nutrition Biosciences Aps Method for the preparation of an enzyme tablet
AU2014292288B2 (en) * 2013-07-18 2020-04-09 Chr. Hansen A/S Milk clotting aspartic protease enzyme composition
KR101547133B1 (en) 2013-11-19 2015-08-25 재단법인 경북바이오산업연구원 Cereals powder compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928566A (en) * 1970-08-14 1975-12-23 Du Pont Lyophilized biological products
US3932943A (en) * 1970-08-14 1976-01-20 E. I. Du Pont De Nemours And Company Method of preparation of lyophilized biological products
US3721725A (en) * 1970-08-14 1973-03-20 Du Pont Process for preparing powder blends
US4551177A (en) * 1984-04-23 1985-11-05 National Starch And Chemical Corporation Compressible starches as binders for tablets or capsules
JPS62269685A (en) * 1986-05-15 1987-11-24 Showa Denko Kk Enzymic granule
JPH048288A (en) * 1990-04-26 1992-01-13 Amano Pharmaceut Co Ltd Production of enzyme-containing readily disintegrable tablet

Also Published As

Publication number Publication date
AU6995094A (en) 1995-01-17
EP0703779A1 (en) 1996-04-03
AU681159B2 (en) 1997-08-21
DK0703779T3 (en) 2002-02-18
NZ267601A (en) 1996-11-26
JPH08511430A (en) 1996-12-03
EP0703779B1 (en) 2001-10-31
DE69428897D1 (en) 2001-12-06
KR960703005A (en) 1996-06-19
WO1995000121A1 (en) 1995-01-05
ES2167368T3 (en) 2002-05-16
KR100370257B1 (en) 2003-04-26
BR9406845A (en) 1996-04-16
ATE207739T1 (en) 2001-11-15
JP3559042B2 (en) 2004-08-25
CA2165284A1 (en) 1995-01-05
DE69428897T2 (en) 2002-07-18
CN1103587C (en) 2003-03-26
CN1125395A (en) 1996-06-26
DK71993D0 (en) 1993-06-18
US5885618A (en) 1999-03-23

Similar Documents

Publication Publication Date Title
PT703779E (en) TABLETS CONTAINING ENZYMES AND PROCESSES FOR THEIR PREPARATION
DK0767830T3 (en) Preparation of a multi-enzyme granule
PT98710A (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED INDOLIL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU4304196A (en) Novel sulfonamides
CA2241266A1 (en) Enzyme composition for tissue dissociation
EA199700110A1 (en) COMPOSITION WITH HIGH CONTENT OF ACETAMINOPHEN FOR DIRECT PRESSING
DE69535328D1 (en) IN-VITRO GROWTH OF LANGERHANS'SCHEN ISLANDS AND ITS USES
NO983825D0 (en) Dosage of ibuprofen
ES2044718T3 (en) PREPARATION CONTAINING ENZYMES AND DETERGENT CONTAINING SUCH PREPARATION.
DE69740161D1 (en) Nateglinide tablets preparations
FI953442A (en) Freeze-dried spheres containing gonadotropin
CA2211494A1 (en) Method for enhancing enzyme activity at elevated temperature
AU7738281A (en) Quick disintigrating tablets with delayed release release pharmacological action
DK0741565T3 (en) Process for the preparation of S (+) - ibuprofen particles
DE3883098D1 (en) SPRAY-DRIED IBUPROFEN COMPOSITIONS.
DE69620607D1 (en) DRIED GRANULATED PRESSED TABLETS CONTAINING DESOGESTREL
AU6087194A (en) Hiv protease inhibitors
IL90414A0 (en) Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals
DK0727983T3 (en) Process for the preparation of a clodronate preparation
ES2113803A1 (en) Method for the treatment of plants with agrochemical tablet compositions
DE69415979D1 (en) Calix (4) arenas
AU2979495A (en) Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments
HUP0101059A2 (en) Detergent tablet and process for its manufacture
ES2016227A4 (en) 54- PROCEDURE FOR THE ELABORATION OF L-ALPHA AMINO ACIDS.
MY114407A (en) Process for the production of a flavouring agent